Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Annual Information Update

1 Jun 2009 11:30

RNS Number : 1205T
Aberdeen Grwth Opp VCT2 PLC
01 June 2009
 

ABERDEEN GROWTH OPPORTUNITIES VCT 2 PLC

ANNUAL INFORMATION UPDATE

The following summarises the information that has been published by the Company since 6 June 2008.

Announcements listed as published on the London Stock Exchange have been published via a Regulatory Information Service and can be found on http://londonstockexchange.com/. (The relevant code for the Company is ABGO.)

Copies of documents at Companies House, including Report and Accounts, can be obtained from Companies House or through Companies House Direct at http:/www.companieshouse.gov.uk/. Further details may also be obtained from the Company via its manager at http://www.aberdeen-asset.com/.

Report and Accounts can also be inspected at the UK Listing Authority's Document Viewing Facility at:

Financial Services Authority

25 The North Colonnade

Canary Wharf

London

E14 5HS

Tel. 020 7676 1000

Some of the information referred to below was provided as at a specific date and may now be out of date.

Date

Description

Place of Filing or Publication

15 May 2009

Result of AGM

London Stock Exchange

15 May 2009

Interim Management Statement

London Stock Exchange

7 April 2009

Dividend Record Date

London Stock Exchange

6 April 2009

Annual Financial Report

London Stock Exchange, UKLA, Companies House

6 April 2009

Change of Adviser

London Stock Exchange

14 November 2008

Result of General Meeting

London Stock Exchange

14 November 2008

Interim Management Statement

London Stock Exchange

28 August 2008

Issue of interim report and circular re General Meeting

London Stock Exchange

14 August 2008

Interim announcement

London Stock Exchange

For further information contact:

Rosemary O'Neil

Company Secretary, Aberdeen Asset Managers Private Equity

Telephone: 0141 306 7553

Email: rosemary.oneil@aberdeen-asset.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUBFLFBKQBLBBK
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.